COVID-19: What to know about the coronavirus pandemic on September 2
- This daily roundup brings you a selection of the latest news and updates on the COVID-19 coronavirus pandemic, along with tips and tools to help you stay informed and protected.
- In the spotlight: up to 1 in 7 children affected by a long COVID – study in English; WHO, Germany opens new intelligence center on pandemics and epidemics; India reports the largest single-day increase in COVID-19 cases in two months.
1. How COVID-19 is affecting the world
Confirmed cases of COVID-19 have exceeded 218.4 million worldwide, according to Johns Hopkins University. The number of confirmed deaths stands at more than 4.54 million. More than 5.34 billion doses of vaccination have been administered worldwide, according to Our World in Data.
Australian doctors have warned hospitals are not ready to face plans to reopen – even with higher vaccination rates – as some states prepare to move from suppression to life with COVID-19.
Moderna has asked the United States Food and Drug Administration to authorize the use of a third booster dose of its COVID-19 vaccine.
New Zealand has reported a drop in new COVID-19 infections, with authorities saying this was a sign that nationwide restrictions were working.
India reported its largest single-day increase in new COVID-19 cases in two months, with the state of Kerala hit the hardest.
A Reuters / Ipsos poll has shown that most vaccinated Americans want a booster dose of the COVID-19 vaccine.
It comes as the European Center for Disease Prevention and Control yesterday said there was no urgent need for vaccine booster doses.
Spain has reached the government’s target of vaccinating 70% of its population against COVID-19.
New daily confirmed COVID-19 cases in Turkey peaked at 23,946 in three weeks.
Pfizer and Merck have announced new trials of their investigational oral antiviral drugs for COVID-19.
2. Up to 1 in 7 children affected by a long COVID – Study in English
Up to 1 in 7 children could show symptoms related to COVID-19 months after testing positive for the disease, according to an English study on COVID in adolescents.
The study, led by University College London and Public Health England, found that 11 to 17 year olds who tested positive for the virus were twice as likely to report three or more symptoms 15 weeks later than those who had tested negative.
The researchers said that although the results suggest that up to 32,000 teens could have multiple symptoms related to COVID-19 after 15 weeks, the prevalence of long COVID in the age group was lower than some feared. last year.
“Overall it’s better than people might have guessed in December,” Professor Terence Stephenson of UCL Great Ormond Street Institute of Child Health told reporters.
The research has not yet been peer reviewed.
The COVID Response Alliance for Social Entrepreneurship is a coalition of 85 world leaders, organized by the World Economic Forum. Its mission: to unite our efforts to support social entrepreneurs around the world as essential first responders to the pandemic and as pioneers of a green and inclusive economic reality.
Its COVID Social Enterprise Action Agenda presents 25 concrete recommendations for key stakeholder groups, including funders and philanthropists, investors, government institutions, support organizations and businesses. In January 2021, its members launched its 2021 roadmap through which its members will roll out an ambitious set of 21 action projects in 10 work areas. Including business access and policy change in support of a social economy.
For more information, see the Alliance’s website or its “Impact Story” here.
3. WHO and Germany open new intelligence platform on pandemics and epidemics
German Chancellor Angela Merkel and Director General of the World Health Organization Dr Tedros Adhanom Ghebreyesus yesterday inaugurated the new WHO hub for pandemic and epidemic intelligence.
The Berlin-based hub will work to partner and develop technology that uses data to detect and fight disease and future epidemics.
“The world must be able to detect new events with pandemic potential and monitor disease control measures in real time to create effective pandemic and epidemic risk management,” said Dr Tedros. “This hub will be the key to this effort, leveraging innovations in data science for public health surveillance and response, and creating systems through which we can share and extend expertise in this area to ‘global scale.’